US newsfromwww.npr.org3 months ago23andMe is filing for bankruptcy. Here's what it means for your genetic data23andMe has filed for bankruptcy amidst financial struggles and concerns over user data privacy.
Marketing techfromwww.mercurynews.com3 months ago23andMe's rise and fall, in four charts23andMe files for Chapter 11 bankruptcy amid declining revenues and consumer data privacy concerns.
OMG sciencefromFuturism3 months ago23andMe Is Crumbling, and That Means Your Genetic Data Is Blowing in the Breeze23andMe has filed for Chapter 11 bankruptcy, raising concerns about user data privacy and potential company takeover.
Startup companiesfromBusiness Insider3 months agoMeet Anne Wojcicki, the 23andMe founder who wants to bid on the company after stepping down as CEOAnne Wojcicki stepped down as CEO of 23andMe amidst the company's bankruptcy protection filing.
NYC startupfromEngadget3 months ago23andMe has filed for bankruptcy and CEO Anne Wojcicki has stepped down23andMe has filed for Chapter 11 bankruptcy amid financial difficulties and a significant data breach.CEO Anne Wojcicki resigns as the company seeks to find a buyer.
Privacy professionalsfromwww.scientificamerican.com3 months ago23andMe Bankruptcy Leaves Troves of Genetic Data at Risk23andMe's bankruptcy raises concerns about the security of sensitive user data and highlights a gap in genetic privacy laws.
US newsfromwww.npr.org3 months ago23andMe is filing for bankruptcy. Here's what it means for your genetic data23andMe has filed for bankruptcy amidst financial struggles and concerns over user data privacy.
Marketing techfromwww.mercurynews.com3 months ago23andMe's rise and fall, in four charts23andMe files for Chapter 11 bankruptcy amid declining revenues and consumer data privacy concerns.
OMG sciencefromFuturism3 months ago23andMe Is Crumbling, and That Means Your Genetic Data Is Blowing in the Breeze23andMe has filed for Chapter 11 bankruptcy, raising concerns about user data privacy and potential company takeover.
Startup companiesfromBusiness Insider3 months agoMeet Anne Wojcicki, the 23andMe founder who wants to bid on the company after stepping down as CEOAnne Wojcicki stepped down as CEO of 23andMe amidst the company's bankruptcy protection filing.
NYC startupfromEngadget3 months ago23andMe has filed for bankruptcy and CEO Anne Wojcicki has stepped down23andMe has filed for Chapter 11 bankruptcy amid financial difficulties and a significant data breach.CEO Anne Wojcicki resigns as the company seeks to find a buyer.
Privacy professionalsfromwww.scientificamerican.com3 months ago23andMe Bankruptcy Leaves Troves of Genetic Data at Risk23andMe's bankruptcy raises concerns about the security of sensitive user data and highlights a gap in genetic privacy laws.
Mental healthfromPsychology Today3 months agoBeyond Trial and Error: How Genes Guide Depression TreatmentPharmacogenomics personalizes depression treatment based on genetic profiles, improving treatment outcomes.
Public healthfromNews Center3 months agoPredicting Disease Risk and Improving Patient Outcomes - News CenterAdvancements in genetic and blood testing are key to diagnosing and preventing chronic diseases proactively.
Venturefrom24/7 Wall St.4 months agoNancy Pelosi's Latest AI Stock Pick Tempus AI Is Up Big TodayTempus AI's acquisition of Ambry Genetics signals a strategic push in the AI healthcare sector.Recent insider selling by CFO raises concerns, but analysts view it as a potential buying opportunity.
Growth hackingfromwww.theguardian.com1 month agoBrain tumour diagnosis could be made within hours, say researchersA new diagnostic method for brain tumours may reduce treatment waiting times from weeks to hours.
Artificial intelligencefromFast Company2 weeks agoAI is Bringing New Hope to the UndiagnosedAI is revolutionizing the diagnosis of complex diseases by enhancing efficiency and speed in interpreting genetic data.
Marketing techfromwww.theguardian.com1 month agoBankrupt DNA testing firm 23andMe to be purchased for $256mRegeneron Pharmaceuticals is acquiring 23andMe for $256 million amidst bankruptcy proceedings, focusing on customer data protection.
Mental healthfromPsychology Today3 months agoBeyond Trial and Error: How Genes Guide Depression TreatmentPharmacogenomics personalizes depression treatment based on genetic profiles, improving treatment outcomes.
Public healthfromNews Center3 months agoPredicting Disease Risk and Improving Patient Outcomes - News CenterAdvancements in genetic and blood testing are key to diagnosing and preventing chronic diseases proactively.
Venturefrom24/7 Wall St.4 months agoNancy Pelosi's Latest AI Stock Pick Tempus AI Is Up Big TodayTempus AI's acquisition of Ambry Genetics signals a strategic push in the AI healthcare sector.Recent insider selling by CFO raises concerns, but analysts view it as a potential buying opportunity.
Growth hackingfromwww.theguardian.com1 month agoBrain tumour diagnosis could be made within hours, say researchersA new diagnostic method for brain tumours may reduce treatment waiting times from weeks to hours.
Artificial intelligencefromFast Company2 weeks agoAI is Bringing New Hope to the UndiagnosedAI is revolutionizing the diagnosis of complex diseases by enhancing efficiency and speed in interpreting genetic data.
Marketing techfromwww.theguardian.com1 month agoBankrupt DNA testing firm 23andMe to be purchased for $256mRegeneron Pharmaceuticals is acquiring 23andMe for $256 million amidst bankruptcy proceedings, focusing on customer data protection.